antibody therapeutics
| 6 min read
Avidity remains on track to submit Biologics License Application at the end of 2025 for accelerated approval
| 2 min read
New funding will support scaling, team expansion, and the launch of customizable solutions for spatial biology, proteomics, and single-cell analysis.
| 3 min read
This recognition signals momentum for next-gen RNA therapeutics designed to enhance delivery and efficacy in treating rare genetic diseases.
| 9 min read
With new insight into IgE biology, a new, two-pronged strategy for eliminating the pathogenic immune cells that lead to allergies emerges.
| 4 min read
A new benchtop system enables real-time live single-cell functional analysis for immune response, antibody discovery, and cell therapy.
| 4 min read
Biotech and pharma leaders reveal the neurological therapies in development that they’re most excited about.
| 7 min read
A new antibody drug should improve treatment of a rare autoimmune encephalitis.
| 2 min read
Scientists leverage the natural ability of antibodies to cross the blood-brain barrier and target proteins implicated in neurodegenerative disease.
Page 1 of 1 - 8 Total Items
